{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T03:26:48Z","timestamp":1788492408551,"version":"build-2803163510"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T00:00:00Z","timestamp":1570752000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T00:00:00Z","timestamp":1570752000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100016328","name":"Quebec Breast Cancer Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016328","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Montreal Jewish General Segal Cancer Centre"},{"name":"Week-end to End Women's Cancers"},{"DOI":"10.13039\/100009326","name":"Cancer Research Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009326","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1245\/s10434-019-07809-7","type":"journal-article","created":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T19:02:58Z","timestamp":1570820578000},"page":"4337-4345","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Axillary Lymph Node Ultrasound Following Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: Results from the SN FNAC Study"],"prefix":"10.1245","volume":"26","author":[{"given":"Dominique","family":"Morency","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinziana","family":"Dumitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Parvez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karyne","family":"Martel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Basik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Robidoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Poirier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire M. B.","family":"Holloway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Gaboury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Sideris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarkis","family":"Meterissian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Boileau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,11]]},"reference":[{"issue":"3","key":"7809_CR1","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s10549-005-9025-7","volume":"95","author":"A Fleissig","year":"2006","unstructured":"Fleissig A, Fallowfield LJ, Langridge CI, et al. Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat. 2006;95(3):279\u201393.","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"7809_CR2","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","volume":"11","author":"DN Krag","year":"2010","unstructured":"Krag DN, Anderson SJ, Julian TB, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11(10):927\u201333.","journal-title":"Lancet Oncol"},{"key":"7809_CR3","unstructured":"National Comprehensive Cancer Network. Breast Cancer (Version 3.2018) (2018). \nhttps:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast.pdf\n\n. Accessed 12 Jan 2019."},{"issue":"10","key":"7809_CR4","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S1470-2045(07)70278-4","volume":"8","author":"DN Krag","year":"2007","unstructured":"Krag DN, Anderson SJ, Julian TB, et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol. 2007;8(10):881\u20138.","journal-title":"Lancet Oncol"},{"issue":"9","key":"7809_CR5","doi-asserted-by":"publisher","first-page":"e0162605","DOI":"10.1371\/journal.pone.0162605","volume":"11","author":"C Geng","year":"2016","unstructured":"Geng C, Chen X, Pan X, Li J. The feasibility and accuracy of sentinel lymph node biopsy in initially clinically node-negative breast cancer after neoadjuvant chemotherapy: a systematic review and meta-analysis. PLoS ONE 2016;11(9):e0162605.","journal-title":"PLoS ONE"},{"issue":"3","key":"7809_CR6","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1200\/JCO.2014.55.7827","volume":"33","author":"JF Boileau","year":"2015","unstructured":"Boileau JF, Poirier B, Basik M, et al. Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study. J Clin Oncol. 2015;33(3):258\u201363.","journal-title":"J Clin Oncol"},{"issue":"14","key":"7809_CR7","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1001\/jama.2013.278932","volume":"310","author":"JC Boughey","year":"2013","unstructured":"Boughey JC, Suman VJ, Mittendorf EA, et al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (alliance) clinical trial. JAMA. 2013;310(14):1455\u201361. \nhttps:\/\/doi.org\/10.1001\/jama.2013.278932\n\n.","journal-title":"JAMA"},{"issue":"7","key":"7809_CR8","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","volume":"14","author":"T Kuehn","year":"2013","unstructured":"Kuehn T, Bauerfeind I, Fehm T, et al. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol. 2013;14(7):609\u201318.","journal-title":"Lancet Oncol"},{"issue":"2","key":"7809_CR9","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.breast.2009.02.004","volume":"18","author":"Y Jung","year":"2009","unstructured":"Jung Y, Young E, Han B, Hee J, Seon S, Yeon S. High-resolution ultrasonographic features of axillary lymph node metastasis in patients with breast cancer. The Breast. 2009;18(2):119\u201322.","journal-title":"The Breast"},{"issue":"3","key":"7809_CR10","doi-asserted-by":"publisher","first-page":"W314","DOI":"10.2214\/AJR.12.9032","volume":"200","author":"B Lee","year":"2013","unstructured":"Lee B, Lim AK, Krell J, et al. The efficacy of axillary ultrasound metastasis in breast cancer. AJR Am J Roentgenol 2013;200(3):W314\u2013320.","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"7809_CR11","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.acra.2016.10.005","volume":"24","author":"GR Vijayaraghavan","year":"2019","unstructured":"Vijayaraghavan GR, Vedantham S, Kataoka M, Debenedectis C, Quinlan RM. The relevance of ultrasound imaging of suspicious axillary lymph nodes and fine-needle aspiration biopsy in the post-ACOSOG Z11 era in early breast cancer. Acad Radiol. 2019;24(3):308\u201315.","journal-title":"Acad Radiol"},{"issue":"30","key":"7809_CR12","doi-asserted-by":"publisher","first-page":"3386","DOI":"10.1200\/JCO.2014.57.8401","volume":"33","author":"JC Boughey","year":"2015","unstructured":"Boughey JC, Ballman K\u00a0V, Hunt KK, et al. Axillary ultrasound after neoadjuvant chemotherapy and its impact on sentinel lymph node surgery: results from the American College Of Surgeons Oncology Group Z1071 Trial (Alliance). J Clin Oncol. 2015;33(30):3386\u201393.","journal-title":"J Clin Oncol"},{"key":"7809_CR13","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.breast.2017.05.015","volume":"35","author":"A Peppe","year":"2017","unstructured":"Peppe A, Wilson R, Pope R, Downey K, Rusby J. The use of ultrasound in the clinical re-staging of the axilla after neoadjuvant chemotherapy (NACT). The Breast. 2017;35:104\u20138.","journal-title":"The Breast"},{"issue":"1","key":"7809_CR14","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1245\/s10434-016-5499-2","volume":"24","author":"D Black","year":"2017","unstructured":"Black D. Axillary ultrasound: for all, for none, to diagnose positive nodes, or to support avoiding sentinel lymph node biopsy altogether. Ann Surg Oncol 2017;24(1):64\u20139.","journal-title":"Ann Surg Oncol"},{"key":"7809_CR15","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.breast.2016.11.012","volume":"31","author":"L Schwentner","year":"2017","unstructured":"Schwentner L, Helms G, Nekljudova V, et al. Using ultrasound and palpation for predicting axillary lymph node status following neoadjuvant chemotherapy\u2014results from the multi-center SENTINA trial. Breast 2017;31:202\u20137.","journal-title":"Breast"},{"issue":"3","key":"7809_CR16","doi-asserted-by":"publisher","first-page":"669","DOI":"10.2214\/AJR.17.18295","volume":"210","author":"HT Le-Petross","year":"2018","unstructured":"Le-Petross HT, Mccall LM, Hunt KK, Mittendorf EA. Axillary ultrasound identifies residual nodal disease after chemotherapy: results from the American College of Surgeons Oncology Group Z1071 trial (alliance). AJR Am J Roentgenol. 2018;210(3):669\u201376.","journal-title":"AJR Am J Roentgenol"},{"issue":"22","key":"7809_CR17","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1056\/NEJMoa1612645","volume":"376","author":"N Masuda","year":"2017","unstructured":"Masuda N, Lee S-J, Ohtani S, et al. Adjuvant capecitabine for breast cancer after preoperative chemotherapy. N Engl J Med. 2017;376(22):2147\u201359.","journal-title":"N Engl J Med"},{"issue":"7","key":"7809_CR18","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1056\/NEJMoa1814017","volume":"380","author":"G Von Minckwitz","year":"2019","unstructured":"Von Minckwitz G, Huang CS, Mano MS, et al. Trastuzumab emtansine for residual invasive HER2-positive breast cancer. N Engl J Med. 2019;380(7):617\u201328.","journal-title":"N Engl J Med"},{"issue":"12","key":"7809_CR19","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","volume":"15","author":"M Donker","year":"2014","unstructured":"Donker M, van Tienhoven G, Straver ME, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2014;15(12):1303\u201310.","journal-title":"Lancet Oncol"},{"issue":"24","key":"7809_CR20","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1200\/JCO.2006.07.4062","volume":"25","author":"A Lucci","year":"2007","unstructured":"Lucci A, Mccall LM, Beitsch PD, et al. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND Alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol. 2007;25(24):3657\u201363.","journal-title":"J Clin Oncol"},{"issue":"10","key":"7809_CR21","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1200\/JCO.2015.64.0094","volume":"34","author":"AS Caudle","year":"2016","unstructured":"Caudle AS, Yang WT, Krishnamurthy S, et al. Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: Implementation of targeted axillary dissection. J Clin Oncol. 2016;34(10):1072\u201378.","journal-title":"J Clin Oncol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-019-07809-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-019-07809-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-019-07809-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T23:04:53Z","timestamp":1602284693000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-019-07809-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,11]]},"references-count":21,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["7809"],"URL":"https:\/\/doi.org\/10.1245\/s10434-019-07809-7","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,11]]},"assertion":[{"value":"15 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dominique Morency, Sinziana Dumitra, Elena Parvez, Karyne Martel, Mark Basik, Andr\u00e9 Robidoux, Brigitte Poirier, Claire M.B. Holloway, Louis Gaboury, Lucas Sideris, Sarkis Meterissian, and Jean-Fran\u00e7ois Boileau have no disclosures to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}